Nature Medicine Published Phase 1 Results of Innovent Biologics’ Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
SAN FRANCISCO and SUZHOU, China, July 17, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announced that Nature Medicine (IF: 58.7) has published the results of the Phase 1 clinical study of IBI343, an innovative...
Health In Tech Supports Foster Closet to Help Children and Families in Need
STUART, Fla., July 17, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, is proud to announce its financial support for Community Foster Closet, a local nonprofit in Spokane Valley, Washington, dedicated to providing free clothing, shoes, diapers, wipes, and other essentials to foster families...
Flat Medical Honored at Premier, Inc.’s Annual Supplier Innovation Celebration
AUSTIN, Texas, July 16, 2025 /PRNewswire/ -- FlatTech LLC, doing business as Flat Medical today announced that it was honored during Premier, Inc.'s annual supplier Innovation Celebration at the 2025 Breakthroughs Conference and Exhibition. The Innovation Celebration recognizes groundbreaking healthcare technologies that have been launched throughout the year and the ways these products are helping to improve the health...
Rwazi Raises $12M to Replace Every Gut Call with an AI Copilot
In a world where delays cost millions, this AI copilot shows teams what's changing, what to do, and what happens next. LOS ANGELES, July 16, 2025 /PRNewswire/ -- Rwazi has raised $12 million in Series A funding to replace every gut call with an AI copilot. The round will accelerate...
SNB-101 Earns Government Backing as Promising Therapy for Small Cell Lung Cancer
SEONGNAM, South Korea, July 16, 2025 /PRNewswire/ -- In a strong endorsement of its cutting-edge drug delivery technology, SN BioScience announced that its anticancer candidate SNB-101 has been selected as a clinical-stage project under the 2025 Korea Drug Development Project, a government-initiated program led by the Korea Drug Development Fund (KDDF). The program includes two years of research support,...
HYROX Returns to Hong Kong with Cigna Healthcare as Title Sponsor for the Second Year, Welcoming Nearly 10,000 Racers on July 26-27
The first-ever Adaptive Men/Women category is set to debut, expanding access and inclusivity in fitness racing HONG KONG, July 16, 2025 /PRNewswire/ -- HYROX, one of the world's fastest-growing indoor fitness races is set to make a triumphant return to Hong Kong as "Cigna Healthcare HYROX Hong Kong 2025"...
The 2025 Mammoth International Contest on Omics Sciences – Young Scientists Track Now Open for Hot Registration!
SHENZHEN, China, July 16, 2025 /PRNewswire/ -- Under the guidance of UNESCO and the United Nations International Cooperation Public Welfare Organization, the 2025 Mammoth International Contest on Omics Sciences - Young Scientist Track (referred to as 2025 MICOS-Youth), co-organized by BGI Research and Jinze Charitable Foundation, was officially launched on May 22, 2025. About the Competition Previously, the Mammoth Cup had held...
WuXi Biologics Granted Highest Negligible-Risk ESG Rating from Morningstar Sustainalytics
Best ESG rating tier of negligible-risk with a top 1% global ranking score Industry and Regional ESG Top-Rated Company for five consecutive years Leader in Green CRDMO to drive innovation for a healthier future SHANGHAI, July 16, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has...
ACTIVE 2.0 Project Launches in Malaysia to Improve Cervical Cancer Treatment
KUALA LUMPUR, Malaysia, July 16, 2025 /PRNewswire/ -- A regional effort to improve cervical cancer care for patients has launched in Malaysia. Involving 6 countries in Southeast Asia, Project ACTIVE 2.0 aims to enhance cervical cancer treatment and support patient recovery across Southeast Asia. The three-year initiative will focus on strengthening healthcare systems through clinical training, infrastructure...
Berlin Heals Announces Publication of Two-Year Clinical Outcomes of Cardiac Microcurrent Therapy in ESC Heart Failure
Study shows sustained improvements in heart failure symptoms and function following long-term C-MIC therapy ZUG, Switzerland, July 16, 2025 /PRNewswire/ -- Berlin Heals, a pioneer in bioelectric medicine for the treatment of heart failure, is pleased to announce the publication of a new peer-reviewed study titled "Two-year outcomes of a cardiac microcurrent...
